ECVAM key area topical toxicity: Update on activities
|
|
- Brook White
- 6 years ago
- Views:
Transcription
1 AATEX 14, Special Issue, Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan ECVAM key area topical toxicity: Update on activities Valérie Zuang, Chantra Eskes, Claudius Griesinger and Thomas Hartung European Centre for the Validation of Alternative Methods, Institute for Health and Consumer Protection, Joint Research Centre, European Commission Corresponding author: Dr Valérie Zuang European Centre for the Validation of Alternative Methods (ECVAM) Institute for Health and Consumer Protection, Joint Research Centre, European Commission I Ispra (Varese), Italy Phone: +(39) , Fax: +(39) , Abstract The European Cosmetics Directive and REACH have accelerated the need for alternative tests. Especially the animal testing ban of cosmetic ingredients from 2009 strongly impacts on the timely delivery of relevant methods. ECVAM's key area "topical toxicity" focuses on skin and eye irritation/corrosion, phototoxicity and percutaneous absorption. Regulatory accepted alternative tests are available for skin corrosion, phototoxicity and percutaneous absorption. In the area of skin irritation, ECVAM recently finalised a study that demonstrates the scientific validity of a human reconstituted skin model to fully replace the animal test. In contrast, eye irritation testing will probably require an integrated testing strategy combining different in vitro assays that altogether might replace the animal test. To this end, ECVAM has contributed to the recent validation of organotypic models for detecting ocular corrosives and severe irritants. In parallel, four promising cytotoxicity- and cell-function- based assays are under evaluation by ECVAM. Finally, ECVAM is planning a prospective validation study on two human reconstituted tissue models. Moreover, the key area contributed to the implementation of the REACH legislation by leading the expert group on skin/eye irritation producing technical guidance for industry on toxicity testing under REACH. Keywords: skin irritation, eye irritation, topical toxicity, validation, ECVAM 1. Introduction Directive 2003/15/EC, the seventh amendment to the Cosmetics Directive prohibits testing of finished products on animals from 2004 and of ingredients by This animal testing ban is reinforced by marketing bans of cosmetics tested on animals from 2004 (finished products), 2009 (acute effects) or 2013 (repeated-dose toxicity, toxicokinetics, reproductive toxicity; EU, 2003). With the REACH legislation, the EU also promotes alternative methods for safety testing (whereas 1 and article 1). In addition, REACH article 25 states that animal testing must be used as a last resort, which encourages the exploitation of useful alternative methods to the absolute maximum. Article 13 states, that information on hazards (especially reg. positives) and risks may be generated even by alternative methods that have not yet been taken up as official regulatory test methods. However, such methods must fulfil the requirements of Annex XI, i.e. must be at least sufficiently well developed according to internationally accepted test development criteria (i.e. ECVAM criteria for entering pre-validation). If such methods are moreover validated, they may be used for identifying positives as well as negatives. At EU level, these two legislations have accelerated the development and optimisation of alternative methods (EU, 2006). The areas which are coordinated and managed by ECVAM in the field of topical toxicity comprise skin and eye irritation, skin corrosion, phototoxicity and percutaneous absorption. All these human health effects fall under the 2009 deadline of the 7 th amendment and the endpoints on skin and eye irritation/corrosion are part of the standard information required in REACH and could lead to testing, using in vitro methods, of up to 20,000 existing chemicals which are marketed in volumes between 1 and 10 tonnes per year (EU, 2006). In addition, the key area provides technical support to the policy Directorate-Generals of the Commission, such as DG Enterprise and DG Health and Consumer Protection, in relation to Directive 76/768/EEC on the approximation of the laws of the Member 2008, Japanese Society for Alternatives to Animal Experiments 523
2 Valérie Zuang, et. al. States relating to cosmetic products, and subsequent amendments, and to the Scientific Committee on Consumer Products (SCCP), respectively. Similarly, the key area provided technical support in the Reach Implementation Project (RIP) 3.3 on the development of Technical Guidance Documents for industry, by chairing the endpoint working group on skin and eye irritation/corrosion, repiratory irritation, contributing to this draft, and by participating in the Drafting Group to finalise the complete guidance document (Anonymous, 2007). 2. Skin irritation/corrosion The ECVAM skin irritation validation study (SIVS) started in November 2003 and ended successfully in May 2006 with the last Management Team meeting of the study. Further to peer-review of the study by the ECVAM Scientific Advisory Committee (ESAC), in April 2007, ESAC issued a statement on the scientific validity of the EPISKIN assay as being a reliable and relevant stand-alone test for predicting rabbit skin irritation, when the endpoint is evaluated by MTT reduction, and for being used as a replacement for the Draize Skin Irritation Test (OECD TG 404 & Method B.4 of Annex V to Directive 67/548/EEC) for the purposes of distinguishing between R38 skin irritant and no-label (non-skin irritant) test substances (ESAC, 2007a). The IL-1α endpoint was regarded as a useful adjunct to the MTT assay, as it has the potential to increase the sensitivity of the test, without reducing its specificity. This endpoint could be used to confirm negatives obtained with the MTT endpoint. The EpiDerm model was considered to reliably identify skin irritants due to its high specificity, but negative results might require further testing [e.g. according to the tiered strategy, as described in the OECD TG 404, (OECD, 2004a)]. The ESAC recommended that improvement of the EpiDerm protocol should be made to increase the level of sensitivity. Several background documents to the study are available on the ECVAM website ( ec.europa.eu under "Download study documents") and the manuscripts on the validation study, as well as on the chemicals selection, were published (Spielmann et al., 2007; Eskes et al., 2007). An EU test method guideline on human skin model assays for skin irritation testing was drafted and submitted to the EU National Coordinators of Testing Methods. Submission of the test guideline by the Commission at OECD level is also foreseen whether in parallel, or after regulatory acceptance of the method in Europe. Follow-up studies to the SIVS are currently being planned such as e.g., the evaluation of the betweenlaboratory reproducibility of the second endpoint IL-1 alpha release and the identification/optimisation/ development of alternative methods which could classify chemicals according to the Globally Harmonised System for classification and labelling of dermal irritancy, i.e. as strong (category 2), mild (category 3) and non-irritants (no category). 2.1 Similar tests With regard to the validation of similar tests to the validated ones for the purposes of skin irritation and/ or skin corrosion testing, several other reconstituted human epidermis models are at different stages of evaluation/validation: The SkinEthic human epidermal model was endorsed by ESAC as being able to distinguish between corrosive and non-corrosive chemicals within the context of the OECD Test guideline 431 in 2006 (ESAC, 2006). The same model but applied to skin irritation testing will be evaluated in a joint validation project by ECVAM's topical toxicity key area and the reference laboratory CORRELATE during The EST-1000 skin irritation assay (Cellsystems) is currently undergoing an external catch-up validation study and the results will be submitted to ECVAM. The same model, but applied to skin corrosion testing is currently being peer-reviewed by ESAC. 2.2 Research To further the development of mechanistic parameters, ECVAM assessed two promising new predictive technologies in the framework of its in-house research: toxicogenomics as well as toxico-metabonomics. The outcome of the toxicogenomics approach was published in 2007 (Borlon et al., 2007). The study investigated the expression of 240 genes following subcytotoxic treatments of 4 skin irritants and 4 non-irritants and used the validated human reconstituted epidermis model EPISKIN. Results indicated that about 50 genes showed differential expression for at least one test chemical when compared to the seven others. Among these, there were genes taking part in stress response, cell signalling, inflammation, protein metabolism, etc. Interestingly, it could be observed that the genes found to be significantly upregulated are not direct inducers of apoptosis, stressing that the genes identified are important in the relevant processes triggered by chemically induced trauma, i.e. inflammation or mild tissue remodelling, including cell division. It was also possible to discriminate specific compounds effects from more general ones. Sixteen genes were down-regulated in the tissues exposed to irritant compounds and up-regulated, or unchanged in tissues exposed to non-irritant compounds when compared to control tissues. These genes could represent useful biomarkers of transcriptomic response triggered by irritant chemicals and could serve to discriminate irritant from non-irritant chemicals. Although the first results are promising, only 8 chemicals were tested. Expanding the number of chemicals assessed will show whether such 524
3 genomic markers can reliably be used as predictors for corrosion and irritation. Such toxicogenomic mapping, together with a toxico-proteomic approach to confirm whether the genes identified as differentially expressed (i.e. upregulated) are really translated into augmented protein levels, might increase our understanding of the pathways of toxicity involved in corrosion and irritation and thus aid the development of even better tests in the future. The other in-house research project based on a metabonomic approach for the screening of skin irritation is on-going. The same in vitro model (i.e. EPISKIN ) in combination with the same chemicals and protocols was used. The project follows the metabolic "foot-printing" approach analysing differential changes in extracellular metabolites released into the culture media. Changes of the metabolic state restricted to the cell interior ("fingerprinting" technique) are not yet assessed. So far, the project succeeded in identifying differential but yet unidentified peaks (the so-called "metabolic foot print") in response to irritant chemicals which are absent in controls and non-irritants. Such specific patterning of peaks together with their identification might lead to the identification of biomarkers useful to predict toxicity or provide better understanding of toxicity pathways, especially when combined with a toxicogenomic and toxicoproteomic strategy. However, since mass spectroscopy is a rather expensive method, the metabonomic approach which has clearly demonstrated its capacity to distinguish irritants from non-irritants, needs now to establish whether it is more powerful than classical endpoints. 3. Eye irritation ECVAM has focused its work programme in the area of eye irritation on: - the recommendations on the necessary efforts to progress alternative methods validation and animal test replacement for eye irritation (Eskes et al, 2005) outlined in the report on "Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects" (Eskes & Zuang, 2005) - the recommendation from the ECVAM Task Force on Eye Irritation which met several times since its establishment in June Substantial progress has been made in the different areas of activities as described below. In addition ECVAM is working in close collaboration with ICCVAM, COLIPA and industry in general in order to streamline and harmonise global validation efforts and avoid duplication of work. 3.1 Evaluation of in vitro assays Two organotypic assays, the Bovine Corneal Opacity and Permeability (BCOP) assay, and the Isolated Chicken Eye (ICE) test were endorsed by ESAC in April 2007 for the identification of severe irritants (ESAC, 2007b). Such statement was based on the results and conclusions from the ICCVAMled retrospective study carried out in collaboration with ECVAM from Following the ESAC statement, EU Test Guidelines on the two assays are currently under preparation. For the two other organotypic assays evaluated, the Hen's Egg Test on the Chorio-allantoic Membrane (HET- CAM) assay and the Isolated Rabbit Eye (IRE) test, ESAC requested that further work was performed before a statement on their validity to identify severe eye irritants could be made. It is important to note nevertheless that all four have been accepted already in 2004 by EU competent authorities for the identification of severe eye irritants (EC, 2004). With regard to the evaluation of these four organotypic assays for identifying mild or non irritants, a retrospective validation of the collected data is foreseen. A retrospective validation of four cytototoxicyand cell function- based assays, i.e., the Neutral Red Release, the Red Blood Cell test, the Fluorescein Leakage assay and the Cytosensor Microphysiometer was initiated in October 2005 and is expected to be finalised by early The study is coordinated by an International Validation Management Group, and is based on the retrospective collection of existing data compiled according to the ECVAM Modular Approach to Validation and Weight-of-Evidence principles (Hartung et al., 2004; Balls et al., 2006). Based on the final results, i.e. if there is sufficient evidence of sufficiently high quality to support the validity of the methods, the assays may proceed towards ESAC for peer review. Two Human Reconstituted Tissue models, the SkinEthic Human Corneal Epithelium and the EpiOcular T M OCL-200 model were positively reviewed by the ECVAM Eye Irritation Task Force which recommended protocol improvements and the organisation of a workshop to plan for a formal validation study. The two assays are currently undergoing protocol optimisation and assessment in a multi-industrial trial coordinated by COLIPA. When available, the findings from the multiindustrial trial will be considered for the planning of an ECVAM prospective validation study. In the meantime, ECVAM is setting up the necessary actions groups (validation management team, chemicals selection group) required to perform the formal and independent validation trial. Additional assays which were submitted to ECVAM are also currently under evaluation. These encompass the Low Volume Eye Test (LVET) as a refinement assay, the Ocular Irritection assay and the Slug Mucosal Irritation (SMI) assay amongst others. A first submission of the LVET was received in Following the ECVAM request for further information and the recommendations from the 525
4 Valérie Zuang, et. al. ECVAM Task Force on Eye Irritation, a final dossier based on retrospective evidence compiled according to the Modular Approach was submitted to ECVAM by the test proposer in February The assay is currently under peer-review by ESAC. With regard to the Ocular Irritection assay, a dossier based on retrospective and prospective information is currently being prepared according to the Modular Approach to Validation by the test method proposer. Finally, for SMI assay the results of a prevalidation study coorganised by university and industry, have just been submitted to ECVAM for review and consideration. 3.2 Testing Strategies Promising test strategies for eye irritation have been suggested during an ECVAM Expert Meeting comprising more than 30 participants from industries, CROs, regulators, academia and welfare organisations (Scott et al., in preparation). The performances and applicability domains which will be determined in the evaluation of individual alternative methods, as mentioned above, will be combined based on the proposed strategies and evaluated in order to determine the most suitable strategies that utilise the strengths of specific in vitro assays to classify test substances according to their irritation potential. 3.3 Mechanistically-based assays Although the assays currently under evaluation appear promising for specific purposes and applicability domains, they may not model completely all aspects and mechanisms of ocular toxicity in vivo, e.g. tissue remodelling, modelling the full inflammatory response. To achieve full replacement of the animal test, it is recommended beside the use of test strategies, to advance in parallel the development of mechanistically-based models in order to address the currently existing mechanistic gaps (Eskes et al., 2005). In May 2005, a joint ICCVAM-ECVAM symposium was organised on "Mechanisms of Chemically- Induced Ocular Injury and Recovery" where 76 scientists from governmental institutions, academia and industry participated. The participants discussed and identified those mechanistic aspects of ocular irritation where further investigation and development are required (Hamernik et al., 2006). Currently, the COLIPA eye irritation research program addresses some of these mechanistic features (Jones et al., 2006). In addition, individual efforts exist within the scientific community to develop more complex test systems and biomarkers for eye irritation. ECVAM is closely following these efforts to ensure that the most mechanistically relevant assays can proceed towards validation according to internationally agreed principles and eventually contribute, in combination with the most advanced assays to the full replacement of the animal test. 4. Acute phototoxicity Further to an international EU/ECVAM/COLIPA validation exercise it was proven that the phototoxic potential of chemicals in humans can correctly be predicted by the 3T3-NRU in vitro phototoxicity test (3T3-NRU-PT; Spielmann et al., 1994; Spielmann et al., 1998). This in vitro test gained regulatory acceptance in all EU Member States in 2000 (EC, 2000) and in the OECD Member States in 2004 (OECD, 2004b). The test is now widely used in the chemical and cosmetic industries. Subsequently, the usefulness of reconstructed human skin model assays as a supplementary assay to the 3T3-NRU PT test was demonstrated in several studies (Jones et al., 2003; Lelièvre et al., 2007; Liebsch et al., 1995; Liebsch et al., 1997; Liebsch et al., 2005; Portes et al., 2002). These studies showed that a true phototoxic potential of a chemical which is correctly predicted i n t h e 3 T 3 - N R U - P T m a y b e m o d i f i e d a n d modulated when applied topically to the skin at low concentrations (e.g. in formulations) and additional information on phototoxicity linked to barrier function, tissue distribution and bioavailability of the chemical in the skin may be needed. The reconstructed human skin model assays represent a useful tool for confirmation of nonphototoxic and phototoxic samples identified by the 3T3 NRU PT. However, further investigations are currently on-going by testing a wider range of chemicals. 5. Skin absorption/penetration In vitro tests for the determination whether a chemical penetrates through skin received regulatory acceptance at OECD level in 2004 (OECD, 2004c) and were introduced into Annex V through the 30 th ATP at EU level in In vitro methods for skin absorption measure the diffusion of chemicals across excised human or pig skin in flow through or static diffusion cells. An OECD guidance document for the conduct of skin absorption studies describes the circumstances in which the use of the in vitro method would be appropriate (OECD, 2004d). In 2007, preliminary results on an in vitro test based on reconstituted human epidermis (RHE) models were submitted to ECVAM for evaluation. The advantages of this test method are the adequate availability of RHE models, the shorter duration of the experiments and possibly also the investigation of skin metabolism in skin tissue of human origin (Schäfer-Korting, 2006). 6. Policy support 6.1 Directive 76/768/EEC on the regulation of cosmetic products Scientific and technical support is continuously provided to ECVAM's customer Directorate Generals 526
5 (DG) such as e.g. DG Enterprise and DG Health & Consumer Protection, with regard to the development, validation and legal acceptance of alternative methods to animal testing. This consists, among others, in the annual reporting on the status of alternative methods in the framework of the 7 th amendment to the Cosmetics Directive, in the participation in the Interservice Steering Group (ISG) on the recast of the Cosmetics Directive, and in the recently created International Cooperation on Cosmetics Regulation (ICCR). The purpose of the multilateral framework of the International Cooperation on Cosmetics Regulations (ICCR) is to maintain the highest level of global consumer protection, while minimising barriers to international trade. The ICCR group is composed of regulatory authorities from the US, Japan, European Union and Canada. This group of regulatory authorities defined as "members" can enter into a constructive dialogue with their relevant cosmetics' industry trade associations. The ICCR members' representatives normally meet once a year, but may alter frequency of meetings if considered necessary to ensure progress. One of the main pillar of current discussions focus on the harmonisation in the acceptance and interpretation by independent peer review bodies, on the usefulness and limitations of in vitro tests based on the results of validation studies. 6.2 REACH ECVAM steered the REACH Implementation Project (RIP 3.3-2) on the development of Technical Guidance Documents for industry on eleven human health and environmental endpoints. In particular, the ECVAM key area on Topical Toxicity chaired the endpoint working group on skin and eye irritation/corrosion and respiratory irritation and participated in the Drafting Group to finalise the complete guidance document. In the REACH guidance documentation, Intelligent Testing Strategies (ITS) have been developed for all REACH endpoints. Since these strategies are described at a general level, considerable research is still needed to develop endpoint-specific strategies in more detail, and to assess their impacts, including their benefits (e.g. reduced animal testing) and potential costs (e.g. consequence of incorrect predictions). As an illustration of research needed to further develop endpoint-specific ITS, ECVAM and ECB have been developing ITS for skin irritation, as a means of exploring the applicability of novel concepts in the design and evaluation of ITS. The work is further described in Hoffmann et al. (2008). 7. Conclusions Important progress was made in the development, validation and legal acceptance of alternative methods in the field of topical toxicity. Indeed, many successes took place in this field during the last seven years and most of the current validated and accepted alternative methods belong to the field of topical toxicity. These are methods for skin corrosion, phototoxicity and skin penetration and more recently, the successful ECVAM validation study, where a full replacement method to the regulatory animal test was validated for the purposes of skin irritation testing. In the field of eye irritation, an ambitious programme was set up in 2004 in order to be able to meet the deadline of 2009 imposed by the 7 th amendment to the Cosmetics Directive. Twelve methods are currently under validation and test strategies combining the different tests according to their strengths and applicability domains were identified. The scientific validity of in vitro methods for the identification of severe eye irritant chemicals were endorsed by ESAC in April The next 2-3 years will be dedicated to the validation of in vitro methods for the other ranges of eye irritation, i.e. mild and non-irritant. Once the evaluations of the individual assays will be completed, the results will be combined and statistically evaluated in order to determine the most suitable strategies to classify test substances according to their irritation potential and ultimately replace the Draize rabbit eye test. With regard to policy support, the key area will continue to provide technical and scientific recommendations to its policy DGs, especially with regard to cosmetics testing. References Anonymous (2007). Draft Technical Guidance Document to Industry on the Information Requirements for REACH Part 2. Chapter 7.2 on Skin- and eye irritation/corrosion and respiratory irritation. p Website: it/documents/reach/rip_final_reports/rip_3.3_i NFO_REQUIREMENTS/FINAL_DRAFT_GUIDANCE/ RIP3.3_TGD_FINAL_ _Part2.pdf (accessed on ) Balls M., Amcoff P., Bremer S., Casati S., Coecke S., Clothier R., Combes R., Corvi R., Curren R., Eskes C., Fentem J., Gribaldo L., Halder M., Hartung T., Hoffmann S., Schechtman L., Scott L., Spielmann H., Stokes W., Tice R., Wagner D., Zuang V. (2006). The principles of weight of evidence validation of test methods and testing strategies. ATLA 34, Borlon, C., Godard, P., Eskes, C., Hartung, T., Zuang, V. and Toussaint, O. (2007) The usefulness of toxicogenomics for predicting acute skin irritation on in vitro reconstructed human epidermis. Toxicology 241(3), EC (2000) Commission Directive 2000/33/EC of 25 April 2000 adapting to technical progress for the 27th time Council Directive 67/548/EC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Annex V B.41 Phototoxicity - in vitro 3T3 NRU phototoxicity test. Official Journal of the European Communities L136, EC (2004). Manual of Decisions for Implementation of the 6th and 7th Amendments to Directive 67/548/EEC on 527
6 Valérie Zuang, et. al. Dangerous Substances. Updated version of July 2004 (EUR 20519). 189pp. Ispra, Italy: European Chemicals Bureau, European Commission JRC. Website: DOCUMENTS/New-Chemicals/Manual_of_decisions.pdf (accessed on ). ESAC (2006) Statement on the Application of the Skinethic TM Human Skin Model.for skin corrosivity testing. Available at: under "Publications", "ESAC statements", accessed on ESAC (2007a) Statement on the validity of in vitro tests for skin irritation. Available at: eu/ under "Publications", "ESAC statements", accessed on ESAC (2007b) ESAC Statement on the conclusions of the ICCVAM retrospective study on Organotypic in vitro assays as screening tests to identify potential ocular corrosives and severe irritants as determined by US EPA, EU (R41) AND UN GHS classifications in a tiered testing strategy, as part of a weight of evidence approach. Available at: under "Publications", "ESAC statements", accessed on Eskes, C. & Zuang, V. (2005) Alternative (Non-Animal) Methods for Cosmetics Testing: Current Status and Future Prospects. ATLA 33 Suppl. 1, Eskes, C., Bessou, S., Bruner, L., Curren, R., Harbell, J., Jones, P., Kreiling, R., Liebsch, M., McNamee, P., Pape, W., Prinsen, M., Seidle, T., Vanparys, P., Worth, A., Zuang, V. (2005). Subchapter 3.3. Eye Irritation. In Alternative (nonanimal) Methods for Cosmetics Testing: Current Status and Future Prospects (Eskes C., Zuang V. eds). ATLA 33, Suppl. 1, Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. & Zuang.V (2007) ECVAM International Validation Study on In Vitro Tests for Acute Skin Irritation: Selection of Test Chemicals. ATLA 35, EU (2003) Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European Union L66, EU (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/ EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union L396, Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A.J., Prieto, P., Sabbioni, E., Scott, L., Worth, A. & Zuang, V. (2004). A Modular Approach to the ECVAM Principles on Test Validity. ATLA 32, Hoffmann, S., Gallegos Saliner A, Patlewicz G, Eskes C, Zuang V & Worth A (2008). A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals. Toxicology Letters XX, submitted. Jones, P.A., King, A.V., Earl, L.K. and Lawrence, R.S. (2003) An assessment of the phototoxic hazard of a personal product ingredient using in vitro assays. Toxicology In Vitro 17(4), Jones P., Bagley D., Faller C., Le Varlet B., McNamee P., Manou I., Pape w., Van den Berghe C., Van Goethem F. (2006). An Overview of the COLIPA Eye Irritation Research Programme. ALTEX 23 Suppl, Lelièvre, D., Justine, P., Christiaens, F., Bonaventure, N., Coutet, J., Marrot, L., Cotovio, J. (2007) The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicology In Vitro 21(6), Liebsch, M., Döring, B., Donelly, T.A., Logemann, P., Rheins, L.A. & Spielmann, H. (1995). Application of the human dermal model Skin2 ZK 1350 to phototoxicity and skin corrosivity testing. Toxicology in Vitro 9, Liebsch, M., Barrabas, C., Traue, T. & Spielmann, H. (1997) Entwicklung eines in vitro Tests auf dermale Phototoxizitaet in einem Modell menschlicher Epidermis (EpiDerm TM ). ALTEX 14, Liebsch, M., Spielmann, H., Pape, W., Krul, C., Deguercy, A., & Eskes, C. (2005) UV-induced Effects in Alternative (Non-Animal) Methods for Cosmetics Testing: Current Status and Future Prospects. Eskes, C. and Zuang, V. (eds.). ATLA 33 Suppl. 1, OECD (2004a). OECD Guidelines for the Testing of Chemicals No. 404: Acute Dermal Irritation/Corrosion, 13pp. Paris, France: Organisation for Economic Cooperation and Development. OECD (2004b). OECD Guidelines for the Testing of Chemicals No. 432: In Vitro 3T3 NRU phototoxicity test. 15pp. Paris, France: Organisation for Economic Co-operation and Development. OECD (2004c). OECD Guidelines for the Testing of Chemicals No. 428: Skin absorption: in vitro method, 8pp. Paris, France: Organisation for Economic Cooperation and Development. OECD (2004d). Guidance Document for the Conduct of Skin Absorption Studies., Environment Directorate. In OECD Environmental Health and Safety Publications, Series on Testing and Assessment No. 28. Paris, France: Organization for Economic Cooperation and Development. Portes, P., Pygmalion, M.J., Popovic, E., Cottin, M. and Mariani, M. (2002) Use of human reconstituted epidermis Episkin for assessment of weak phototoxic potential of chemical compounds. Photodermatol Photoimmunol Photomed.18(2), Schäfer-Korting, M., Bock, U., Gamer, A., Haberland, A., Haltner-Ukomadu, E., Kaca, M., Kamp, H., Kietzmann, M., Korting, H-C., Krächter, H-U., Lehr, C-M., Liebsch, M., Mehling, A., Netzlaff, F., Niedorf, F., Rübbelke, M.K., Schäfer, U., Schmidt, E., Schreiber, S., Schröder, K.-R., Spielmann, H. and Vuia1, A. (2006) Reconstructed Human Epidermis for Skin Absorption Testing: Results of the German Prevalidation Study. ATLA 34, Spielmann, H., Balls, M., Brand, M., Döring, B., Holzhütter, H.G., Kalweit, S., Klecak, G., L`Epattenier, H., Liebsch, M., Lovell, W.W., Maurer, T., Moldenhauer, F., Moore, L., Pape, W.J.W., Pfannenbecker, U., Potthast, J., De Silva, O., Steiling, W. & Willshaw, A. (1994). EC/COLIPA project on in vitro phototoxicity testing: first results obtained with the Balb/c 3T3 cell phototoxicity assay. Toxicology in Vitro 8, Spielmann, H., Balls, M., Dupuis, J., Pape, W.J.W., Pechovitch, G. De Silva, O., Holzhütter, H.G., Clothier, R., Desolle, P., Gerberick, F., Liebsch, M., Lovell, W.W., Maurer, T., Pfannenbecker, U., Potthast, J. M., Csato, M., Sladowski, D., Steiling, W., and Brantom, P. (1998). The international EU/COLIPA In vitro phototoxicity validation study: results of phase II (blind trial), part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro 12, Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J., Eskes, C., Roguet, R., Cotovió, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandárová, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I. and Zuang, V. (2007) The ECVAM International Validation Study on In Vitro Tests for Acute Skin Irritation: Report on the Validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test. ATLA 35,
ESAC STATEMENT ON THE PERFORMANCE STANDARS (PS) FOR IN VITRO SKIN IRRITATION TESTING USING RECONSTRUCTED HUMAN EPIDERMIS. Contents
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ESAC STATEMENT ON THE PERFORMANCE STANDARS (PS) FOR IN VITRO SKIN IRRITATION TESTING USING RECONSTRUCTED
More informationECVAM s Activities in Validating Alternative Tests for Skin Corrosion and Irritation
ATLA 30, Supplement 2, 61 67, 2002 61 ECVAM s Activities in Validating Alternative Tests for Skin Corrosion and Irritation Julia H. Fentem 1 and Philip A. Botham 2 1Safety & Environmental Assurance Centre
More informationInstitute for In Vitro Sciences
Outline Introduction to the Institute for In Vitro Sciences, Inc. Pathways to In Vitro Methods Acceptance In Vitro Methods Currently Accepted at OECD Level Traditional Acceptance Paradigm Alternative Approaches
More informationAlternative Testverfahren und intelligente Teststrategien Position der EU-Kommission. Thomas Hartung & ECVAM Team.
Alternative Testverfahren und intelligente Teststrategien Position der EU-Kommission Thomas Hartung & ECVAM Team Institute for Health and Consumer Protection (IHCP) Ispra (Va), Italy http://ecvam.jrc.it
More informationSTATEMENT ON THE SCIENTIFIC VALIDITY OF IN-VITRO TESTS FOR SKIN IRRITATION TESTING
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 STATEMENT ON THE SCIENTIFIC VALIDITY OF IN-VITRO TESTS FOR SKIN IRRITATION TESTING At its 29th meeting,
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EN EN EN EUROPEAN COMMISSION Brussels, 16.9.2010 COM(2010) 480 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Report on the Development, Validation and Legal Acceptance of
More informationSTATEMENT ON THE VALIDITY OF IN-VITRO TESTS FOR SKIN IRRITATION
EUROPEAN COMMISSION DIRECTORATE GENERAL JRC JOINT RESEARCH CENTRE Institute for Health and Consumer Protection European Centre for the Validation of Alternative Methods (ECVAM) STATEMENT ON THE VALIDITY
More informationPERFORMANCE STANDARDS FOR ASSESSMENT OF PROPOSED SIMILAR OR MODIFIED IN VITRO
PERFORMANCE STANDARDS FOR ASSESSMENT OF PROPOSED SIMILAR OR MODIFIED IN VITRO RECONSTRUCTED HUMAN EPIDERMIS (RhE) TEST METHODS FOR SKIN IRRITATION (IN RELATION TO TG 439) INTRODUCTION (Intended for the
More informationDevelopments in making in vitro tests available for REACH
Integrated testing strategies for REACH 1 st SETAC Europe Special Science Symposium 1 Developments in making in vitro tests available for REACH S. Bremer, S.Casati, S. Coecke, R. Corvi, L.Gribaldo, M.Halder,
More informationInternational Pre-validation and Validation Studies
Symposium 20th Anniversary of ZEBET at BfR and 50 Years of the 3Rs Principle October 26-27, 2009 Federal Institute for Risk Assessment (BfR), Berlin, International Pre-validation and Validation Studies
More informationMEMORANDUM on. "Alternative Test Methods in Human Health Safety Assessment of Cosmetic Ingredients in the European Union"
Scientific Committee on Consumer Safety SCCS MEMORANDUM on "Alternative Test Methods in Human Health Safety Assessment of Cosmetic Ingredients in the European Union" The SCCS adopted this memorandum at
More informationAlternative (Non-animal) Methods for Chemicals Testing: Current Status and Future Prospects
Alternative (Non-animal) Methods for Chemicals Testing: Current Status and Future Prospects A Report prepared by ECVAM and the ECVAM Working Group on Chemicals Edited by Andrew Worth and Michael Balls
More informationAre the data collection procedures and selection clearly defined? YES
ESAC Peer review of submission of the follow-up validation study of the Modified EpiDerm TM Skin Irritation Test (SIT) for hazard identification and labelling of chemicals according to EU classification
More informationCOMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 11.3.2013 COM(2013) 135 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the animal testing and marketing ban and on the state of play
More informationThe Contributions of the European Cosmetics Industry to the Development of Alternatives to Animal Testing: Dialogue with ECVAM and Future Challenges
ATLA 30, Supplement 2, 189 193, 2002 189 The Contributions of the European Cosmetics Industry to the Development of Alternatives to Animal Testing: Dialogue with ECVAM and Future Challenges Odile de Silva
More informationFood for Thought on Alternative Methods for Cosmetics Safety Testing
Food for Thought on Alternative Methods for Cosmetics Safety Testing Thomas Hartung EU JRC, TRiVA unit, Ispra, Italy This is the first article of this series published after I changed responsibility (see
More informationGuideline on the principles of regulatory acceptance of 3Rs (replacement, reduction, refinement) testing approaches
15 December 2016 EMA/CHMP/CVMP/JEG-3Rs/450091/2012 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on the principles of regulatory
More informationIntroduction to the Third Annual FRAME Lecture, by Professor Horst Spielmann, Presented at the Royal Society of Medicine, London, on 9 October 2001
ATLA 29, 635 648, 2001 635 Introduction to the Third Annual FRAME Lecture, by Professor Horst Spielmann, Presented at the Royal Society of Medicine, London, on 9 October 2001 Michael Balls European Centre
More informationIn Vitro Testing in Contract Research: A Valid Alternative? Robert Guest Head of Alternative and Acute Toxicology
In Vitro Testing in Contract Research: A Valid Alternative? Robert Guest Head of Alternative and Acute Toxicology Primary Objectives Presentation Outline Contract Research Organisations Setting the Scene
More informationAn NGO Perspective on Regulatory Acceptance of Non-animal Data and Related Issues. Martin Stephens, Ph.D. The Humane Society of the United States
An NGO Perspective on Regulatory Acceptance of Non-animal Data and Related Issues Martin Stephens, Ph.D. The Humane Society of the United States Animal Use Numbers Rabbits 222,167 Guinea pigs 203,098 Hamsters
More informationAnimal Use in the Safety Evaluation of Chemicals: Harmonization and Emerging Needs
Animal Use in the Safety Evaluation of Chemicals: Harmonization and Emerging Needs Horst Spielmann Abstract An overview is provided of the legal framework in Europe for the use of experimental animals
More informationOroxcell Cellular Toxicity
Oroxcell 2009 Cellular Toxicity Table of contents Cellular Toxicity 1. Episkin Episkin model by SkinEthic Skin corrosion Skin irritation 2. Reconstructed Human Epidermis (RHE) RHE model by SkinEthic Validation
More informationESAC Peer review of submission of external catch up validation study of In vitro Reconstructed Human Epidermis (RHE) assay for Skin Irritation Testing
ESAC Peer review of submission of external catch up validation study of In vitro Reconstructed Human Epidermis (RHE) assay for Skin Irritation Testing The above submission was sent to ECVAM in the Test
More informationOECD GUIDELINE FOR THE TESTING OF CHEMICALS
OECD/OCDE 439 Adopted: 22 July 2010 OECD GUIDELINE FOR THE TESTING OF CHEMICALS In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method INTRODUCTION 1. Skin irritation refers to the production
More informationPERFORMANCE STANDARDS FOR APPLYING HUMAN SKIN MODELS TO IN VITRO SKIN IRRITATION TESTING
PERFORMANCE STANDARDS FOR APPLYING HUMAN SKIN MODELS TO IN VITRO SKIN IRRITATION TESTING CONTENT 1 GENERAL PURPOSE... 2 2 SPECIFIC PURPOSE AND BACKGROUND... 2 3 INTRODUCTION... 2 3.1 REGULATORY RATIONALE
More informationMethod Review by the Interagency Coordinating Committee for the Validation of Alternative Methods (ICCVAM)
Method Review by the Interagency Coordinating Committee for the Validation of Alternative Methods (ICCVAM) ICCVAM was created as an ad-hoc committee in 1994 and became a standing Committee in 2000. ICCVAM
More informationOECD GUIDELINES FOR THE TESTING OF CHEMICALS DRAFT REVISED GUIDELINE 439:
OECD GUIDELINES FOR THE TESTING OF CHEMICALS DRAFT REVISED GUIDELINE 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method INTRODUCTION 1. Skin irritation refers to the production of
More informationNON-ANIMAL APPROACHES TO SAFETY ASSESSMENT OF COSMETIC PRODUCTS. Cutting-Edge Science and Constant Innovation: The Keys to Success
NON-ANIMAL APPROACHES TO SAFETY ASSESSMENT OF COSMETIC PRODUCTS Cutting-Edge Science and Constant Innovation: The Keys to Success 2 NON-ANIMAL APPROACHES TO SAFETY ASSESSMENT OF COSMETIC PRODUCTS Cutting-Edge
More informationEURL ECVAM. A broader role for greater impact. Maurice Whelan. Head of Systems Toxicology Unit and EURL ECVAM
EURL ECVAM A broader role for greater impact Maurice Whelan Head of Systems Toxicology Unit and EURL ECVAM Institute for Health and Consumer Protection DG Joint Research Centre Meeting of the EP Intergroup
More informationEURL ECVAM progress report on the development, validation and regulatory acceptance of alternative methods ( )
EURL ECVAM progress report on the development, validation and regulatory acceptance of alternative methods (2010-2013) Prepared in the framework of Directive 76/768/EEC and Regulation (EC) No 1223/2009
More informationDRAFT GUIDANCE DOCUMENT ON AN INTEGRATED APPROACH ON TESTING AND ASSESSMENT (IATA) FOR SERIOUS EYE DAMAGE AND EYE IRRITATION DRAFT VERSION 1 SUMMARY:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 DRAFT GUIDANCE DOCUMENT ON AN INTEGRATED APPROACH ON TESTING AND ASSESSMENT (IATA) FOR SERIOUS EYE DAMAGE AND
More informationOECD GUIDELINES FOR THE TESTING OF CHEMICALS DRAFT REVISED GUIDELINE 439: Revised TG 439, 28 November 2014
OECD GUIDELINES FOR THE TESTING OF CHEMICALS DRAFT REVISED GUIDELINE 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method INTRODUCTION 1. Skin irritation refers to the production of
More informationMB Expands Capabilities Adds Ames Test, MTD and Range Finding
What's New @ MB? MB Expands Capabilities - Ames, PK, MTD, Range Finding New! - PorCORA - Non-Animal Ocular Irritation/Reversibility Test Under Development - PorFocal - Low-Level Ocular Irritation Screening
More informationThe European partnership for alternative approaches to animal testing
AATEX 14, Special Issue, 769-773 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan The European partnership for alternative approaches to animal
More informationEUSAAT Linz (Austria) October The JaCVAM validation study of the ROS in vitro photoxicity assay
EUSAAT2013 - Linz (Austria) 15-18 October 2012 The JaCVAM validation study of the ROS in vitro photoxicity assay Dr. med. Horst Spielmann Professor for Regulatory Toxicology, FU Berlin & Sate Animal Welfare
More informationTHE PROCESS OF VALIDATION THE POINT OF VIEW OF THE CRO
THE PROCESS OF VALIDATION THE POINT OF VIEW OF THE CRO Serena Cinelli, Isabella Andreini, Marco Corvaro http://www.remanet.net/ 12th ECOPA Annual Workshop Madrid, 2011 The role of contract organization
More informationPEER REVIEW PANEL REPORT ON THE RETROSPECTIVE VALIDATION OF CYTOTOXICITY/CELL-FUNCTION BASED IN VITRO ASSAYS (EYE IRRITATION)
PEER REVIEW PANEL REPORT ON THE RETROSPECTIVE VALIDATION OF CYTOTOXICITY/CELL-FUNCTION BASED IN VITRO ASSAYS (EYE IRRITATION) Background To satisfy in-house decision making and statutory requirements,
More informationNews from NICEATM and ICCVAM
News from NICEATM and ICCVAM U.S. Agencies accept ICCVAMrecommended In Vitro Estrogen Receptor Testing Methods U.S. Federal agencies have agreed with recommendations made by the Interagency Coordinating
More informationThe National Health Surveillance System. March 31 st Agência Nacional de Vigilância Sanitária
The National Health Surveillance System Agência Nacional de Vigilância Sanitária March 31 st 2015 www.anvisa.gov.br ANVISA Mission: To promote and protect the population health and to act on the risks
More informationNational Health Surveillance System (SNVS)
November 19 th, 2014 The National Health Surveillance System National Health Surveillance System (SNVS) Integrates the Unified Health System (SUS) Integrated by the Federal, State and Local level Coordinated
More informationUpdate from the Japanese Center for the Validation of Alternative Methods (JaCVAM)
ATLA 41, 435 441, 2013 435 Update from the Japanese Center for the Validation of Alternative Methods (JaCVAM) Hajime Kojima a Japanese Center for the Validation of Alternative Methods (JaCVAM), National
More informationProgress Toward Replacing Animals in Toxicity Testing for Cosmetics
Progress Toward Replacing Animals in Toxicity Testing for Cosmetics The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More informationAPPLICATION OF ALTERNATIVE METHODS IN THE REGULATORY ASSESSMENT OF CHEMICAL SAFETY RELATED TO HUMAN EYE IRRITATION & SEVERE EYE IRRITATION
R/RT(2009)3/2 APPLICATION OF ALTERNATIVE METHODS IN THE REGULATORY ASSESSMENT OF CHEMICAL SAFETY RELATED TO HUMAN EYE IRRITATION & SEVERE EYE IRRITATION CURRENT STATUS AND FUTURE PROSPECTS Developed for
More informationPeer Review Panel Evaluation
LabCyte EPI-MODEL24 In Vitro Skin Corrosion Test Method Peer Review Panel Evaluation of the Performance-based Validation Study on the LabCyte EPI-MODEL24 in vitro skin corrosion test method as a me-too
More informationECVAM s role in making alternative methods available for European legislation
ECVAM s role in making alternative methods available for European legislation Thomas Hartung & ECVAM Team Institute for Health and Consumer Protection (IHCP) Ispra (Va), Italy http://ecvam.jrc.it ECVAM
More informationActivities Reporting Dr Tzutzuy Ramirez
Activities Reporting Dr Tzutzuy Ramirez BASF, Industry Co-Chair of EPAA Steering Committee 1 Regulatory acceptance of alternative approaches as a Lead theme 2014 at a glance Preparing for the Future Progressed
More informationSerious Eye Damage and Eye Irritation Webinar. 4 December 2014, 4:00pm GMT
Serious Eye Damage and Eye Irritation Webinar 4 December 2014, 4:00pm GMT Today s webinar This webinar will: Discuss the drivers of in vivo classification for serious eye damage and eye irritation in order
More informationValidation of the 21 st Century Toxicology Toolbox: Challenges, Opportunities, and the Way Forward
Validation of the 21 st Century Toxicology Toolbox: Challenges, Opportunities, and the Way Forward William S. Stokes 1, Judy Strickland 2, and Warren Casey 1 1 National Toxicology Program Interagency Center
More informationREVISED DRAFT OECD GUIDELINE FOR THE TESTING OF CHEMICALS
REVISED DRAFT OECD GUIDELINE FOR THE TESTING OF CHEMICALS Fluorescein Leakage Test Method for Identifying Ocular Corrosives and Severe Irritants INTRODUCTION 1. The Fluorescein Leakage (FL) test method
More informationOur practical examples of International validation studies for establishing OECD test guidelines
July, 2013, Seoul Our practical examples of International validation studies for establishing OECD test guidelines Hajime Kojima, JaCVAM, NIHS 1 Contents 1. ICATM cooperation 2. JaCVAM validation studies
More informationRegulatory Toxicology and Pharmacology
Regulatory Toxicology and Pharmacology 54 (2009) 197 209 Contents lists available at ScienceDirect Regulatory Toxicology and Pharmacology journal homepage: www.elsevier.com/locate/yrtph A tiered approach
More informationWorkshop 3.3 Forum of national and international institutions funding
Workshop 3.3 Forum of national and international institutions funding ECVAM and its collaborative efforts to ensure a better co-ordination and funding of research, development and validation of alternative
More informationEvaluation of two In vitro Testing Methods for Determining Skin Irritation and Corrosivity for Johnson & Johnson.
Evaluation of two In vitro Testing Methods for Determining Skin Irritation and Corrosivity for Johnson & Johnson. Prepared by: Jenna ***** April 17, 2003 This report compares CORROSITEX and EpiDerm TM
More informationComparing the Challenges in Developing and Implementing 3Rs Alternative Methods in Europe and the United States: Industrial and Academic Perspectives*
Comparing the Challenges in Developing and Implementing 3Rs Alternative Methods in Europe and the United States: Industrial and Academic Perspectives* Chantra Eskes 1, Kristie Sullivan 2, Marilyn Aardema
More informationOcular Safety: A Silent (In Vitro) Success Story
ATLA 30, Supplement 2, 69 74, 2002 69 Ocular Safety: A Silent (In Vitro) Success Story Rodger D. Curren and John W. Harbell Institute for In Vitro Sciences, Inc., Suite 220, 21 Firstfield Road, Gaithersburg,
More informationJSAAE & JaCVAM Joint Workshop International Trends on 3Rs in Animal Experiments 14 February 2011, Tokyo
JSAAE & JaCVAM Joint Workshop International Trends on 3Rs in Animal Experiments 14 February 2011, Tokyo The FP7 Project AXLR8 Accelerating the transition to a toxicity pathway-based paradigm for chemical
More informationAPPENDIX IV OECD GUIDELINES FOR TESTING OF CHEMICALS. 1- The OECD Test Guidelines submission and adoption process
APPENDIX IV OECD GUIDELINES FOR TESTING OF CHEMICALS 1- The OECD Test Guidelines submission and adoption process The OECD Test Guidelines Programme provides the mechanism for developing new Test Guidelines,
More informationOECD GUIDELINE FOR THE TESTING OF CHEMICALS
4 April 2012 OECD GUIDELINE FOR THE TESTING OF CHEMICALS DRAFT PROPOSAL FOR AN UPDATE OF TEST GUIDELINE 431 In Vitro Skin Corrosion: Reconstructed Human Epidermis (RhE) Test Method INTRODUCTION 1. Skin
More informationOECD GUIDELINES FOR THE TESTING OF CHEMICALS
OECD/OCDE 431 Adopted: 26 July 2013 OECD GUIDELINES FOR THE TESTING OF CHEMICALS In vitro skin corrosion: reconstructed human epidermis (RHE) test method INTRODUCTION 1. Skin corrosion refers to the production
More informationEUROPEAN COMMISSION TO THE PRESIDENT AND MEMBERS OF THE COURT OF JUSTICE OF THE EUROPEAN UNION WRITTEN OBSERVATIONS
Ref. Ares(2015)1505777-08/04/2015 EUROPEAN COMMISSION Brussels, 8th April 2015 sj.h(2015)1240258 TO THE PRESIDENT AND MEMBERS OF THE COURT OF JUSTICE OF THE EUROPEAN UNION WRITTEN OBSERVATIONS submitted
More informationWhat can be done from regulatory side?
Federal Agency for Medicines and Health Products (FAMHP) What can be done from regulatory side? 9th Annual ecopa Workshop November 29-30, 2008, Brussels Dr. Sonja BEKEN Non-Clinical Assessor, Registration
More informationOPINION "REPORT FOR ESTABLISHING THE TIMETABLE FOR PHASING OUT ANIMAL TESTING FOR THE PURPOSE OF THE COSMETICS DIRECTIVE"
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS OPINION CONCERNING "REPORT FOR ESTABLISHING THE TIMETABLE FOR PHASING OUT ANIMAL TESTING FOR THE PURPOSE OF THE
More informationCosmetics Europe LRSS Programme
Cosmetics Europe LRSS Programme 2016-20 Rob Taalman Objectives of CE Research To deliver tools & strategies for animal-free safety assessment Accurate Robust Efficient ultimately accepted by regulators
More informationRisk assessment and safety compliance of nanotechnology-based products Regulatory mechanisms, guidelines and good practices
May 3, 2017 Risk assessment and safety compliance of nanotechnology-based products Regulatory mechanisms, guidelines and good practices Rawiwan Maniratanachote, Ph.D. rawiwan@nanotec.or.th National Nanotechnology
More informationInconsistencies in data requirements of EU legislation involving tests on animals
Inconsistencies in data requirements of EU legislation involving tests on animals Dipl. Biol. Kristina Wagner Scientific officer for alternatives to animal experiments Animal Welfare Academy, Neubiberg
More informationOECD GUIDELINE FOR THE TESTING OF CHEMICALS
Version 1 November 2011 OECD GUIDELINE FOR THE TESTING OF CHEMICALS DRAFT PROPOSAL FOR AN UPDATE OF TEST GUIDELINE 431 In Vitro Skin Corrosion: Reconstructed Human Epidermis (RhE) Test Method INTRODUCTION
More informationGertrude-Emilia Costin, Ph.D., M.B.A.
The Intersection of Predictive Toxicology Roadmaps - Tox21, FDA s Predictive Tox Roadmap, and ToxCast Gertrude-Emilia Costin, Ph.D., M.B.A. 25 October 2018 Modernizing Predictive Toxicology for Regulatory
More informationOECD/OCDE OECD GUIDELINE FOR THE TESTING OF CHEMICALS. In vitro skin corrosion: reconstructed human epidermis (RHE) test method
Adopted: 29 July 2016 OECD GUIDELINE FOR THE TESTING OF CHEMICALS In vitro skin corrosion: reconstructed human epidermis (RHE) test method INTRODUCTION 1. Skin corrosion refers to the production of irreversible
More informationTHE FUTURE OF IN VITRO SCREENING IN THE DEVELOPMENT OF NEW DRUGS. Hajime Kojima, JaCVAM, NIHS, Japan
THE FUTURE OF IN VITRO SCREENING IN THE DEVELOPMENT OF NEW DRUGS Hajime Kojima, JaCVAM, NIHS, Japan 1 3Rs of animal use (Russel and Burch 1959) Reduction (of animal use) Refinement (to lessen pain or distress
More informationInstitute for Health and Consumer Protection European Centre for the Validation of Alternative Methods (ECVAM)
EUROPEAN COMMISSION Curriculum Vitae 1. Name, Gender, Nationality Family Name Name Gender Nationality JÍROVÁ DAGMAR Female Czech 2. Overall Scientific Expertise Please specify in keywords (see section
More informationExtrapolation of in vitro effects to in vivo embryotoxicity Basic requirements for prediction model development. Han van de Sandt, PhD
Extrapolation of in vitro effects to in vivo embryotoxicity Basic requirements for prediction model development Han van de Sandt, PhD TNO: Netherlands Organisation for Applied Scientific Research Established
More informationExploring new approaches to assess safety without animal testing
AATEX 14, Special Issue, 15-20 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan Exploring new approaches to assess safety without animal testing
More informationDEVELOPMENT OF INTEGRATED APPROACHES TO TESTING AND ASSESSMENT AT OECD
DEVELOPMENT OF INTEGRATED APPROACHES TO TESTING AND ASSESSMENT AT OECD Joint Cefic LRI/Cosmetics Europe/EPAA workshop 23-24 April 2015 Promoting the regulatory use of alternative test methods The OECD
More informationUS EPA Perspectives on GHS SCHC Fall Meeting. Kaitlin Keller, Pesticide Re-evaluation Division Office of Pesticide Programs, USEPA September 27, 2017
1 US EPA Perspectives on GHS SCHC Fall Meeting Kaitlin Keller, Pesticide Re-evaluation Division Office of Pesticide Programs, USEPA September 27, 2017 2 Background: GHS GHS was adopted by the UN in 2003;
More informationDavid Owen Shell Chemicals Ltd ISRTP Workshop, Baltimore November 2005
REACH: alternatives and tiered strategies David Owen Shell Chemicals Ltd ISRTP Workshop, Baltimore November 2005 Contents Background and scope Components of REACH Information requirements Implementation
More informationOECD GUIDELINES FOR THE TESTING OF CHEMICALS DRAFT REVISED GUIDELINE 431:
OECD GUIDELINES FOR THE TESTING OF CHEMICALS DRAFT REVISED GUIDELINE 431: In vitro skin corrosion: reconstructed human epidermis (RHE) test method INTRODUCTION 1. Skin corrosion refers to the production
More informationJSAAE REPORT: VALIDATION STUDY OF IN VITRO SKIN IRRITATION TEST USING LABCYTE EPI-MODEL 24 ( 2 ND REPORT)
JSAAE REPORT: VALIDATION STUDY OF IN VITRO SKIN IRRITATION TEST USING LABCYTE EPI-MODEL 24 ( 2 ND REPORT) JULY 22, 2009 LABCYTE VALIDATION MANAGEMENT TEAM page 1 MEMBERS OF LABCYTE VALIDATION MANAGEMENT
More informationDevelopment of a Non-Animal Testing Strategy for Ocular Hazard Labeling of Some Specific EPA-Regulated Products
Development of a n-animal Testing Strategy for Ocular Hazard Labeling of Some Specific EPA-Regulated Products John R. Fowle III 1, John C. Redden 2, Timothy F. McMahon 2, and Rodger D. Curren 3 1 U.S.
More informationROLE OF OECD AND THE TEST GUIDELINES PROGRAMME IN THE REGULATORY ACCEPTANCE OF ALTERNATIVE METHODS
ROLE OF OECD AND THE TEST GUIDELINES PROGRAMME IN THE REGULATORY ACCEPTANCE OF ALTERNATIVE METHODS Anne Gourmelon Principal Administrator OECD Test Guidelines Programme Environmental, Health and Safety
More informationNon-Animal Testing Technologies and Strategies: Supporting Global Product Stewardship. Presentation outline
Non-Animal Testing Technologies and Strategies: Supporting Global Product Stewardship Gertrude-Emilia Costin, Ph.D., M.B.A. 29 September 2018 Presentation outline Background Current regulatory climate
More informationSTREAMLINED SUMMARY DOCUMENT SUPPORTING OECD TEST GUIDELINE 438 ON THE ISOLATED CHICKEN EYE FOR EYE IRRITATION/CORROSION
Unclassified ENV/JM/MONO(2013)12/PART1 ENV/JM/MONO(2013)12/PART1 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 21-Jun-2013
More informationTen Years of REACH An Animal Protection Perspective
ATLA 46, 347 373, 2018 347 Ten Years of REACH An Animal Protection Perspective Katy Taylor European Coalition to End Animal Experiments (ECEAE) and Cruelty Free International Trust, London, UK Summary
More informationDRAFT UPDATED GUIDELINE 437 FOR THE TESTING OF CHEMICALS
December 01 1 1 1 1 1 1 1 1 1 0 0 1 DRAFT UPDATED GUIDELINE FOR THE TESTING OF CHEMICALS Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and
More information(The persons above are listed in no particular order and their titles are omitted.)
The Draft Minutes of the Proceedings of the 3 rd Meeting (in the fiscal year from 2007 to 2008) of The Advisory Council about the Studies on the Development and the Evaluation of Ultramodern Safety Test
More informationThe Integrated Use of Alternative Methods in Toxicological Risk Evaluation
ATLA 27, 229 237, 1999 229 The Integrated Use of Alternative Methods in Toxicological Risk Evaluation ECVAM Integrated Testing Strategies Task Force Report 1 Bas J. Blaauboer, 1 Martin D. Barratt 2 and
More informationExperimental study on a novel chemical application procedure for in vitro skin corrosivity testing using the Vitrolife-Skin human skin model
ORIGINAL ARTICLE Morikawa N et al., AATEX 11(1),68-78, 2005 Experimental study on a novel chemical application procedure for in vitro skin corrosivity testing using the Vitrolife-Skin human skin model
More informationIn vitro skin corrosion: reconstructed human epidermis (RHE) test method
OECD GUIDELINES FOR THE TESTING OF CHEMICALS DRAFT REVISED GUIDELINE 431: In vitro skin corrosion: reconstructed human epidermis (RHE) test method INTRODUCTION 1. Skin corrosion refers to the production
More informationEndocrine disruptors: EURL ECVAM activities related to validation
The European Commission s science and knowledge service Joint Research Centre Endocrine disruptors: EURL ECVAM activities related to validation Elise Grignard 1 EU legislative background on endocrine disruptors
More informationSafety Evaluation Study Using Embryonic Stem (ES) Cells
Safety Evaluation Study Using Embryonic Stem (ES) Cells Sumitomo Chemical Co., Ltd. Environmental Health Science Laboratory Nobuyuki HORIE Hashihiro HIGUCHI Satoshi KAWAMURA Koichi SAITO Noriyuki SUZUKI
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More informationDeputy Director General of Enterprise and Industry DG. Global Cooperation on alternatives (3Rs) to animal testing
Ref. Ares(2012)1356871-16/11/2012 SPEECH Antti PELTOMÄKI Deputy Director General of Enterprise and Industry DG Opening speech for the 8 th EPAA Annual Conference Global Cooperation on alternatives (3Rs)
More informationEvaluation of Alternative Methods for Assessing Acute Toxicity of Mixtures. Raja S. Settivari, BVSc&AH, PhD, DABT Dow Chemical Company
Evaluation of Alternative Methods for Assessing Acute Toxicity of Mixtures Raja S. Settivari, BVSc&AH, PhD, DABT Dow Chemical Company 1 Purpose Evaluation of alternative methods for: Testing formulations/mixtures
More informationPeer Review Panel Evaluation of the Reactive Oxygen Species (ROS) Photosafety Assay
Peer Review Panel Evaluation of the Reactive Oxygen Species (ROS) Photosafety Assay Japanese Center for the Validation of Alternative Methods National Institute of Health Sciences Tokyo, Japan Table of
More informationCOMMUNICATION FROM THE COMMISSION. on the European Citizens' Initiative "Stop Vivisection"
EUROPEAN COMMISSION Brussels, 3.6.2015 C(2015) 3773 final COMMUNICATION FROM THE COMMISSION on the European Citizens' Initiative "Stop Vivisection" EN EN 1. INTRODUCTION "Stop Vivisection" is the third
More informationMixture Hazard Assessment Methodology
Mixture Hazard Assessment Methodology March 2018 Written in collaboration with ToxServices LLC Copyright 2017 Cradle to Cradle Products Innovation Institute No part of this publication is to be reproduced
More informationDr. Annelie Struessmann Technical Director, CONUSBAT Johannesburg, 16. October 2012
Dr. Annelie Struessmann Technical Director, CONUSBAT Johannesburg, 16. October 2012 1 REACH & THE EU COSMETICS REGULATION - RESULTS AND GAINS IN A WORLD WIDE PERSPECTIVE 2 Gains from Regulatory Affairs
More informationTOWARDS GLOBAL HARMONIZATION OF 3RS IN BIOLOGICALS EFFORTS OF THE EPAA BIOLOGICALS TEAM
TOWARDS GLOBAL HARMONIZATION OF 3RS IN BIOLOGICALS EFFORTS OF THE EPAA BIOLOGICALS TEAM Dr. Katrin Schütte, European Commission co-chair of the EPAA Biologicals project team Karatsu, Japan Nov 15, 2016
More informationIntegrated Approaches to Testing and Assessment (IATA) ex. Skin Sensitisation
Integrated Approaches to Testing and Assessment (IATA) ex. Skin Sensitisation João Barroso 10 th EPAA Annual Conference Brussels, 2014 Conventional Toxicology Chemical Animal model Pancreatic tumor Observe
More informationINVITTOX Protocol No. 118 EPISKIN Skin Corrosivity Test. Index
INVITTOX Protocol No. 118 EPISKIN Skin Corrosivity Test Index Page No. A. Protocol Introduction 2 B. Technical Description (Step-by-step details) 5 C. Literature 25 D.. Annexes 26 A. Protocol Introduction
More informationOur Business. in vitro / in vivo. in vitro / in vivo ADME. in vitro / in vivo. Toxicology. Cell Battery V79. Analytical Services. Service.
GenPharmTox is one of the few CROs who can guarantee the success of our project within the given time framework and on the terms agreed. Dr. Michael Runkel, Apogepha GmbH 3 3 In vitro 3.1. Phototoxicity
More information